{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:25:47Z","timestamp":1761823547180,"version":"build-2065373602"},"reference-count":109,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.revmed.2012.12.008","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T09:31:48Z","timestamp":1360834308000},"page":"269-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cortico\u00efdes et\u2026 infections, dopage, chirurgie et sexualit\u00e9"],"prefix":"10.1016","volume":"34","author":[{"given":"O.","family":"Grossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"G\u00e9n\u00e9reau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2012.12.008_bib0005","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.revmed.2007.05.030","article-title":"Corticoth\u00e9rapie syst\u00e9mique et risque infectieux","volume":"28","author":"Dussauze","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.12.008_bib0010","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/ard.2006.057265","article-title":"Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis","volume":"66","author":"Franklin","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/08916930500285352","article-title":"Infections and SLE","volume":"38","author":"Zandman-Goddard","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.revmed.2012.12.008_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2012.12.008_bib0025","unstructured":"Chatam W. Glucocorticoid effect on the immune system. UpToDate 2012. http:\/\/www.uptodate.com\/home (consult\u00e9 le 21\u00a0oct\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0891-5520(05)70154-9","article-title":"Infections associated with steroid use","volume":"15","author":"Klein","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.revmed.2012.12.008_bib0035","unstructured":"Saag K, Furst D. Major side effects of systemic glucocorticoids. UpToDate 2012. http:\/\/www.uptodate.com\/home (consult\u00e9 le 21\u00a0oct\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0040","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2334-4-42","article-title":"Autoimmune inflammatory disorders, systemic corticosteroids and Pneumocystis pneumonia: a strategy for prevention","volume":"4","author":"Sowden","year":"2004","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0248-8663(03)00138-3","article-title":"Valeur de l\u2019\u00e9osinop\u00e9nie dans le diagnostic des syndromes inflammatoires\u00a0: un \u00ab\u00a0vieux\u00a0\u00bb marqueur revisit\u00e9","volume":"24","author":"Gil","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.12.008_bib0055","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.revmed.2011.04.001","article-title":"Profil \u00e9tiologique et pronostique des valeurs extr\u00eames (\u2265\u00a0500\u00a0mg\/L) de prot\u00e9ine C-r\u00e9active\u00a0: \u00e9tude r\u00e9trospective de 168\u00a0valeurs chez 113\u00a0patients","volume":"32","author":"Hajek","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.12.008_bib0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semarthrit.2009.10.004","article-title":"Serum procalcitonin in systemic autoimmune diseases\u2013where are we now","volume":"40","author":"Buhaescu","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.12.008_bib0065","series-title":"H\u00e9patite B","first-page":"77","article-title":"\u00c9pid\u00e9miologie de l\u2019h\u00e9patite B","author":"Antona","year":"2009"},{"key":"10.1016\/j.revmed.2012.12.008_bib0070","series-title":"H\u00e9patite B","first-page":"443","article-title":"D\u00e9pistage, pr\u00e9vention et traitement de la r\u00e9activation virale B en oncoh\u00e9matologie et chez les patients immunod\u00e9prim\u00e9s","author":"Lalazar","year":"2009"},{"key":"10.1016\/j.revmed.2012.12.008_bib0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.revmed.2011.07.013","article-title":"Prise en charge du risque de r\u00e9activation du virus de l\u2019h\u00e9patite B chez les patients trait\u00e9s par immunosuppresseurs et immunomodulateurs en m\u00e9decine interne\u00a0: donn\u00e9es de l\u2019enqu\u00eate REACTI-B et proposition d\u2019un algorithme de prise en charge","volume":"33","author":"Terrier","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.12.008_bib0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection","volume":"57","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.revmed.2012.12.008_bib0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.revmed.2012.12.008_bib0090","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008\u00a0recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.12.008_bib0095","unstructured":"Le calendrier des vaccinations et les recommandations vaccinales 2012\u00a0selon l\u2019avis du Haut Conseil de la Sant\u00e9 Publique. Institut de Veille Sanitaire. Bulletin \u00c9pid\u00e9miologique Hebdomadaire no\u00a014\u201315\u00a0du avril 2012."},{"key":"10.1016\/j.revmed.2012.12.008_bib0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"Van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.12.008_bib0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0761-8425(04)71306-6","article-title":"Recommandations pour la prise en charge de la tuberculose en France","volume":"21","author":"Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise","year":"2004","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.revmed.2012.12.008_bib0115","unstructured":"Pr\u00e9vention et prise en charge de la tuberculose en France [Site Internet]. Conseil Sup\u00e9rieur d\u2019Hygi\u00e8ne Publique de France 2003. Consultable sur\u00a0: http:\/\/www.sante.gouv.fr\/IMG\/pdf\/Synthese_et_recommandations_du_groupe_de_travail_sur_la_prevention_et_prise_en_charge_de_la_tuberculose_en_France_2002-2003_.pdf."},{"key":"10.1016\/j.revmed.2012.12.008_bib0120","unstructured":"La tuberculose\u00a0: d\u00e9pistage et diagnostic pr\u00e9coce [Site Internet]. Institut National d\u2019\u00c9ducation et de Pr\u00e9vention pour la Sant\u00e9. Consultable sur\u00a0: http:\/\/www.inpes.sante.fr\/CFESBases\/catalogue\/pdf\/1183.pdf."},{"key":"10.1016\/j.revmed.2012.12.008_bib0125","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","author":"American Thoracic Society","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.revmed.2012.12.008_bib0130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","article-title":"Clinical practice. Latent tuberculosis infection in the United States","volume":"364","author":"Horsburgh","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0135","unstructured":"Pai M, Menzies D. Diagnosis of latent tuberculosis infection in HIV-negative adults. UpToDate 2012. http:\/\/www.uptodate.com\/home (consult\u00e9 le 21\u00a0oct\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0140","unstructured":"Tuberculose et test de d\u00e9tection de l\u2019interf\u00e9ron gamma [Site Internet]. Haut Conseil de la Sant\u00e9 Publique; 2011. Disponible sur\u00a0: http:\/\/www.hcsp.fr\/docspdf\/avisrapports\/hcspr20110701_interferongamma.pdf."},{"key":"10.1016\/j.revmed.2012.12.008_bib0145","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1136\/annrheumdis-2011-200408","article-title":"Influence of replacing tuberculin skin test with ex vivo interferon \u2013 release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy","volume":"71","author":"Mariette","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","article-title":"High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy","volume":"2","author":"Mow","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.revmed.2012.12.008_bib0155","first-page":"1374","article-title":"Age-related risk of hepatotoxicity in the treatment of latent tuberculosis infection: a systematic review","volume":"14","author":"Kunst","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.revmed.2012.12.008_bib0165","unstructured":"Thomas C, Limper A. Epidemiology, clinical manifestations, and diagnosis of Pneumocystis pneumonia in non-HIV-infected patients. UpToDate 2012. http:\/\/www.uptodate.com\/home (consult\u00e9 le 21\u00a0oct\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0170","unstructured":"Thomas C, Limper A. Treatment and prevention of Pneumocystis pneumonia in non-HIV-infected patients. UpToDate 2012. http:\/\/www.uptodate.com\/home (consult\u00e9 le 21\u00a0oct\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0175","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.12.008_bib0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.semarthrit.2011.05.004","article-title":"Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases","volume":"41","author":"Vananuvat","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.12.008_bib0185","first-page":"795","article-title":"Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis","volume":"151","author":"Ognibene","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0190","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.rhu.0000221794.24431.36","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue disease","volume":"12","author":"Li","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.revmed.2012.12.008_bib0195","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0200","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1445-5994.2007.01382.x","article-title":"Audit of Pneumocystis pneumonia in patients seen by the Christchurch Hospital rheumatology service over a 5-year period","volume":"37","author":"Meuli","year":"2007","journal-title":"Intern Med J"},{"key":"10.1016\/j.revmed.2012.12.008_bib0205","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2165\/00003495-200666090-00004","article-title":"Pharmacological therapy for Wegener's granulomatosis","volume":"66","author":"White","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.revmed.2012.12.008_bib0210","first-page":"246","article-title":"Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34\u00a0cases","volume":"21","author":"Godeau","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2012.12.008_bib0215","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/ard.54.12.991","article-title":"Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis","volume":"54","author":"Godeau","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0220","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","article-title":"Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2012.12.008_bib0225","unstructured":"Infections urinaires nosocomiales de l\u2019adulte\u00a0: conf\u00e9rence de consensus de la Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise et de l\u2019Association fran\u00e7aise d\u2019urologie 2002. Texte court. Med Mal Infect 2003;23:375\u201380."},{"key":"10.1016\/j.revmed.2012.12.008_bib0230","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","article-title":"Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults","volume":"40","author":"Nicolle","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0235","article-title":"Testing for urinary tract colonisation before high-dose corticosteroid treatment in acute multiple sclerosis","author":"Rakusa","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.revmed.2012.12.008_bib0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajic.2006.03.001","article-title":"Risk factors for nosocomial urinary tract-related bacteremia: a case-control study","volume":"34","author":"Saint","year":"2006","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.revmed.2012.12.008_bib0245","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1469-0691.2006.01443.x","article-title":"Severe strongyloidiasis in corticosteroid-treated patients","volume":"12","author":"Fardet","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.revmed.2012.12.008_bib0250","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinf.2006.01.016","article-title":"Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review","volume":"54","author":"Fardet","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.revmed.2012.12.008_bib0255","first-page":"191","article-title":"Albendazole is effective treatment for chronic strongyloidiasis","volume":"86","author":"Archibald","year":"1993","journal-title":"Q J Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0260","doi-asserted-by":"crossref","first-page":"e1254","DOI":"10.1371\/journal.pntd.0001254","article-title":"Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis","volume":"5","author":"Bisoffi","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0265","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/169.5.1076","article-title":"A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis","volume":"169","author":"Gann","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0270","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4269\/ajtmh.1996.55.477","article-title":"A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children","volume":"55","author":"Marti","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.revmed.2012.12.008_bib0275","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijantimicag.2007.08.014","article-title":"Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis","volume":"31","author":"Suputtamongkol","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.revmed.2012.12.008_bib0280","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1517\/14656566.5.12.2615","article-title":"Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis","volume":"5","author":"Igual-Adell","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.revmed.2012.12.008_bib0285","unstructured":"Circulaire DGS\/SD7A\/SD5C\/DHOS\/E4\u00a0no\u00a02002\/243\u00a0du 22\u00a0avril 2002\u00a0relative \u00e0 la pr\u00e9vention du risque li\u00e9 aux l\u00e9gionelles dans les \u00e9tablissements de sant\u00e9 [Site Internet]. Disponible sur\u00a0: http:\/\/www.sante.gouv.fr\/fichiers\/bo\/2002\/02-18\/a0181819.htm."},{"key":"10.1016\/j.revmed.2012.12.008_bib0290","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1183\/09031936.00076911","article-title":"Factors associated with hospital mortality in community-acquired legionellosis in France","volume":"39","author":"Chidiac","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2012.12.008_bib0295","unstructured":"Pedro-Botet M, Stout J, Yu V. Epidemiology and pathogenesis of Legionella infection. UpToDate 2012. http:\/\/www.uptodate.com\/home (consult\u00e9 le 21\u00a0oct\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0300","unstructured":"Albrecht M. Post-exposure prophylaxis against varicella-zoster virus infection UpToDate 2012. http:\/\/www.uptodate.com\/home (consult\u00e9 le 21\u00a0oct\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0305","unstructured":"Albrecht M. Clinical features of varicella-zoster virus infection: chickenpox. UpToDate 2012. http:\/\/www.uptodate.com\/home (consult\u00e9 le 21\u00a0oct\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0310","unstructured":"Prise en charge des infections \u00e0 VZV. Texte court de la 11e\u00a0conf\u00e9rence de consensus en th\u00e9rapeutique anti-infectieuse de la Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise. Presse Med 1998;27:1231\u20136."},{"key":"10.1016\/j.revmed.2012.12.008_bib0315","unstructured":"Direction G\u00e9n\u00e9rale de la Sant\u00e9, Comit\u00e9 technique des vaccinations. Guide des vaccinations. \u00c9dition 2012. Saint-Denis: Inpes, coll. Varia; 2012. 488\u00a0p."},{"key":"10.1016\/j.revmed.2012.12.008_bib0320","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.revmed.2012.12.008_bib0325","unstructured":"Barinaga J, Skolnik P. Prevention and treatment of measles. UpToDate 2012. http:\/\/www.uptodate.com\/home (consult\u00e9 le 21\u00a0oct\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0330","unstructured":"Recommandations sanitaires pour les voyageurs. Comit\u00e9 des maladies li\u00e9es aux voyages et des maladies d\u2019importation, Haut Conseil de la Sant\u00e9 Publique. Institut de Veille Sanitaire. Bulletin \u00c9pid\u00e9miologique Hebdomadaire no\u00a020\u201321\u00a0du 29\u00a0mai 2012."},{"key":"10.1016\/j.revmed.2012.12.008_bib0335","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.vaccine.2005.10.007","article-title":"Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients","volume":"24","author":"De Roux","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2012.12.008_bib0340","first-page":"289","article-title":"Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma","volume":"70","author":"Lahood","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.revmed.2012.12.008_bib0345","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0350","unstructured":"Rapport d\u2019activit\u00e9 2011\u00a0du Centre national de r\u00e9f\u00e9rence du pneumocoque [Site Internet]. Paris: Hopital europ\u00e9en Georges-Pompidou; 2011. http:\/\/www.invs.sante.fr\/Espace-professionnels\/Centres-nationaux-de-reference\/Rapports-d-activites-et-liens."},{"key":"10.1016\/j.revmed.2012.12.008_bib0355","doi-asserted-by":"crossref","unstructured":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2012;61:816\u20139.","DOI":"10.1111\/ajt.12073"},{"key":"10.1016\/j.revmed.2012.12.008_bib0360","unstructured":"Jong E, Freedman D. Immunocompromised travelers. Centers for Disease Control and Prevention. [Site Internet] CDC Health Information for International Travel 2012. http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2012\/chapter-8-advising-travelers-with-specific-needs\/immunocompromised-travelers.htm (consult\u00e9 le 21\u00a0oct\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0365","unstructured":"Autorisation d\u2019usage \u00e0 des fins th\u00e9rapeutiques (AUT) [Site Internet]. Agence fran\u00e7aise de lutte contre le dopage. https:\/\/www.afld.fr\/aut (consult\u00e9 le 30\u00a0novembre\u00a02012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0370","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/bjsm.2008.053371","article-title":"Why glucocorticoids should be removed from the World Antidoping Agency's list of banned products","volume":"42","author":"Orchard","year":"2008","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0375","first-page":"549","article-title":"A doping sinner is not always a cheat","volume":"42","author":"Pluim","year":"2008","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0380","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/bjsm.2008.053397","article-title":"Why glucocorticoids ought to be kept on the World Antidoping Agency's list of banned products","volume":"42","author":"Montalvan","year":"2008","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0385","unstructured":"Listes des f\u00e9d\u00e9rations sportives agr\u00e9\u00e9es [Internet]. Minist\u00e8re des Sports, de la Jeunesse, de l\u2019\u00c9ducation populaire et de la Vie associative. http:\/\/www.sports.gouv.fr\/index\/acteurs-du-sport\/les-federations\/liste-des-federations-sportives-2742 (consult\u00e9 le 30\u00a0novembre 2012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0390","unstructured":"Rapport d\u2019activit\u00e9 2011 [Site Internet]. Agence fran\u00e7aise de lutte contre le dopage. https:\/\/www.afld.fr\/documentation\/recherche-de-documentation\/rapport-relatif-7 (consult\u00e9 le 30\u00a0novembre 2012)."},{"key":"10.1016\/j.revmed.2012.12.008_bib0395","unstructured":"AFLD [Site Internet]. https:\/\/www.afld.fr\/ (consult\u00e9 le 30\u00a0novembre 2012)."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.revmed.2012.12.008_bib0400","doi-asserted-by":"crossref","first-page":"i48","DOI":"10.1136\/bjsm.2006.027599","article-title":"Glucocorticosteroids in football: use and misuse","volume":"40","author":"Dvorak","year":"2006","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0405","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ecl.2009.10.001","article-title":"Glucocorticoids: a doping agent","volume":"39","author":"Duclos","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.revmed.2012.12.008_bib0410","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bjsm.2007.045187","article-title":"The use of medication and nutritional supplements during FIFA World Cups 2002\u00a0and 2006","volume":"42","author":"Tscholl","year":"2008","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0415","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00000539-200001000-00038","article-title":"Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review","volume":"90","author":"Henzi","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.revmed.2012.12.008_bib0420","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/bjs.5252","article-title":"Randomized clinical trial of the effect of preoperative dexamethasone on nausea and vomiting after laparoscopic cholecystectomy","volume":"93","author":"Feo","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.revmed.2012.12.008_bib0425","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1399-6576.2004.00480.x","article-title":"Methylprednisolone intravenously 1day after surgery has sustained analgesic and opioid-sparing effects","volume":"48","author":"Romundstad","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.revmed.2012.12.008_bib0430","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.otohns.2005.11.010","article-title":"Steroids for post-tonsillectomy pain reduction: meta-analysis of randomized controlled trials","volume":"134","author":"Afman","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.revmed.2012.12.008_bib0435","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/110241599750008107","article-title":"Preoperative high dose methylprednisolone improves patients outcome after abdominal surgery","volume":"165","author":"Nagelschmidt","year":"1999","journal-title":"Eur J Surg"},{"key":"10.1016\/j.revmed.2012.12.008_bib0440","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000542-197711000-00018","article-title":"Interaction of pancuronium and corticosteroids","volume":"47","author":"Laflin","year":"1977","journal-title":"Anesthesiology"},{"key":"10.1016\/j.revmed.2012.12.008_bib0445","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1213\/01.ANE.0000080611.29106.9E","article-title":"The effects of single-dose dexamethasone on wound healing in rats","volume":"97","author":"Durmus","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.revmed.2012.12.008_bib0450","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/ibd.21331","article-title":"Effect of corticosteroid dose and duration of administration on colonic anastomosis","volume":"16","author":"Baca","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.revmed.2012.12.008_bib0455","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0016-5085(03)00883-7","article-title":"Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients","volume":"125","author":"Aberra","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2012.12.008_bib0460","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/00365521.2012.660540","article-title":"Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease","volume":"47","author":"El-Hussuna","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.revmed.2012.12.008_bib0465","first-page":"327","article-title":"Low incidence of complications in asthmatic patients treated with preoperative corticosteroids","volume":"25","author":"Su","year":"2004","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.revmed.2012.12.008_bib0470","doi-asserted-by":"crossref","unstructured":"Luca F, Taquet MC, Goichot B. Insuffisance surr\u00e9nalienne cortico-induite. Rev Med Interne, http:\/\/dx.doi.org\/10.1016\/j.revmed.2012.12.001.","DOI":"10.1016\/j.revmed.2012.12.001"},{"key":"10.1016\/j.revmed.2012.12.008_bib0475","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00000658-199404000-00013","article-title":"Perioperative glucocorticoid coverage. A reassessment 42years after emergence of a problem","volume":"219","author":"Salem","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.revmed.2012.12.008_bib0480","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/archsurg.143.12.1222","article-title":"Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature","volume":"143","author":"Marik","year":"2008","journal-title":"Arch Surg"},{"key":"10.1016\/j.revmed.2012.12.008_bib0485","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5694\/j.1326-5377.2008.tb01686.x","article-title":"Management of adrenal insufficiency during the stress of medical illness and surgery","volume":"188","author":"Jung","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.revmed.2012.12.008_bib0490","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","article-title":"Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion","volume":"157","author":"Fardet","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2012.12.008_bib0495","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ajp.2011.11071009","article-title":"Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care","volume":"169","author":"Fardet","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.revmed.2012.12.008_bib0500","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1743-6109.2009.01309.x","article-title":"Pathways of sexual desire","volume":"6","author":"Pfaus","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0505","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.yhbeh.2008.04.007","article-title":"Coping with a challenging environment: effects of seasonal variability and reproductive status on glucocorticoid concentrations of female baboons (Papio cynocephalus)","volume":"54","author":"Gesquiere","year":"2008","journal-title":"Horm Behav"},{"key":"10.1016\/j.revmed.2012.12.008_bib0510","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.yhbeh.2011.09.001","article-title":"Acute effects of corticosterone injection on paternal behavior in California mouse (Peromyscus californicus) fathers","volume":"60","author":"Harris","year":"2011","journal-title":"Horm Behav"},{"key":"10.1016\/j.revmed.2012.12.008_bib0515","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1210\/jc.2011-3451","article-title":"ACTH and cortisol response to Dex\/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement","volume":"97","author":"Lee","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.008_bib0520","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinte.160.5.610","article-title":"The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation","volume":"160","author":"Janssen","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2012.12.008_bib0525","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0015-0282(16)42265-X","article-title":"Failure of an intrauterine device concurrent with administration of corticosteroids","volume":"27","author":"Zerner","year":"1976","journal-title":"Fertil Steril"},{"key":"10.1016\/j.revmed.2012.12.008_bib0530","first-page":"975","article-title":"Unexpected pregnancy in a woman using an intrauterine device and receiving steroid therapy","volume":"14","author":"Inkeles","year":"1982","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.revmed.2012.12.008_bib0535","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/humrep\/del208","article-title":"Risk factors for IUD failure: results of a large multicentre case-control study","volume":"21","author":"Thonneau","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.revmed.2012.12.008_bib0540","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/AOG.0b013e318183464e","article-title":"Using an intrauterine device in immunocompromised women","volume":"112","author":"Browne","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.revmed.2012.12.008_bib0545","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/acr.20402","article-title":"Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality","volume":"63","author":"Yazdany","year":"2011","journal-title":"Arthritis Care Res"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886631201185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886631201185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:51Z","timestamp":1759336251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S024886631201185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":109,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S024886631201185X"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2012.12.008","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cortico\u00efdes et\u2026 infections, dopage, chirurgie et sexualit\u00e9","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2012.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}